Condition: Asthma
Intervention: Biological: Mepolizumab
Sponsor: GlaxoSmithKline
Not yet recruiting – verified May 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Nebulizers may not deliver full drug dose to kids with asthma – KFDA
|
Nebulizers may not deliver full drug dose to kids with asthma
KFDA FRIDAY, Dec. 6, 2013 (HealthDay News) — Nebulizers — devices that transform liquid asthma medications into an easy-to-inhale mist — aren't providing people with asthma a full dose of medication, according to a small new study. Researchers found that … |
View full post on asthma – Google News
Asthma nebulizers don’t deliver full dose – Health24.com
|
Asthma nebulizers don't deliver full dose
Health24.com Nebulisers – devices that transform liquid asthma medications into an easy-to-inhale mist – aren't providing people with asthma a full dose of medication, according to a small new study. Researchers found that less than 20% of the prescribed medication … |
View full post on asthma – Google News
Low dose aspirin protects against asthma – The Almagest
The Almagest |
Low dose aspirin protects against asthma
The Almagest There were 113 new cases of asthma in the aspirin group and 145 in the placebo group. Therefore, aspirin was associated with a 22 per cent reduction in risk of newly-diagnosed adult-onset asthma. However, the trial was actually designed to assess … |
View full post on asthma – Google News
Now, asthma inhaler that administers right dose – Zee News
|
Now, asthma inhaler that administers right dose
Zee News London: A 22-year-old college student in the UK, who suffered from acute asthma since he was a child, has developed an inhaler which signals whether a user has taken the right dosage. Josh Averill, an undergraduate in product design at Nottingham Trent … |
View full post on asthma – Google News
A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (Mcg) Combination When Administered in Adult Patients With Asthma
Condition: Asthma
Interventions: Drug: FF/VI 100/25 mcg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting – verified April 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Aptar Pharma dose indicator selected for new asthma combination therapy – Packaging World
 Packaging World |
Aptar Pharma dose indicator selected for new asthma combination therapy
Packaging World It is indicated for the maintenance treatment of asthma in patients aged 12 years and over, and in adults whose symptoms are not adequately controlled on an ICS and an as-required inhaled short-acting beta2-agonist (SABA), and in those patients who are … |
View full post on asthma – Google News
Teva launches asthma treatment inhaler with dose counter – MENAFN.COM
|
Teva launches asthma treatment inhaler with dose counter
MENAFN.COM Jan 06, 2013 (Menafn – Globes – McClatchy-Tribune Information Services via COMTEX) –Teva Pharmaceutical Industries Ltd. TEVA(tase:TEVA) unit Teva Respiratory has launched its ProAir HFA asthma treatment inhaler with a dose counter for use in … |
View full post on asthma – Google News
Teva launches asthma treatment inhaler with dose counter – Globes
|
Teva launches asthma treatment inhaler with dose counter
Globes Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) unit Teva Respiratory has launched its ProAir HFA asthma treatment inhaler with a dose counter for use in patients from age four. The inhaler is for the treatment or prevention of … |
View full post on asthma – Google News
Aptar Pharma dose indicator selected for new asthma combination therapy – Healthcare Packaging
|
Aptar Pharma dose indicator selected for new asthma combination therapy
Healthcare Packaging It is indicated for the maintenance treatment of asthma in patients aged 12 years and over (50/5?g and 125/5?g strengths), and in adults (250/10?g strength) whose symptoms are not adequately controlled on an ICS and an as-required inhaled short-acting … |
View full post on asthma – Google News